Scuderi et al. [12] tested various concentrations of CBD (10−9–10−7 M) in neuroblastoma cells SHSY5YAPP+ with an expression of full-length APP and, it was observed that CBD decreased fragments (C83 and C99) of amyloid precursor protein in a dose-dependent fashion and reduced the expression of Aβ peptide. This evidence concerns the gene APP and neuroblastoma.